Loading…

Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies

Aims:  To compare the sensitivity and specificity of the recently commercially available FLI‐1 monoclonal (FLI‐1m) antibody with the currently used antibodies [CD99 and FLI‐1 polyclonal (FLI‐1p)] in the diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET) and to determine th...

Full description

Saved in:
Bibliographic Details
Published in:Histopathology 2006-12, Vol.49 (6), p.569-575
Main Authors: Mhawech-Fauceglia, P, Herrmann, F, Penetrante, R, Beck, A, Sait, S, Block, A M, Odunsi, K, Fisher, J, Balos, L, Cheney, R T
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims:  To compare the sensitivity and specificity of the recently commercially available FLI‐1 monoclonal (FLI‐1m) antibody with the currently used antibodies [CD99 and FLI‐1 polyclonal (FLI‐1p)] in the diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET) and to determine the diagnostic value of the EWSR1 (22q12) dual‐colour, break‐apart rearrangement probe fluorescence in situ hybridization (FISH) technique. Materials and methods:  Forty‐three cases of well‐documented EWS/PNET and 15 non‐EWS/PNET cases were retrieved from the archival files. Immunohistochemistry (IHC) for FLI‐1p, FLI‐1m and FISH analysis was performed. Results:  The most sensitive and specific test panel for the diagnosis of EWS/PNET is the combination of CD99 and FLI‐1p. FISH had a very high specificity (100%) but only a moderate sensitivity (50%). Conclusion:  The combination of CD99 and FLI‐1p is the method of choice for the diagnosis of EWS/PNET. EWRS1 (22q12) dual‐colour, break‐apart rearrangement probe FISH should be used as a confirmatory test in addition to CD99 and FLI1‐p due to its high specificity.
ISSN:0309-0167
1365-2559
DOI:10.1111/j.1365-2559.2006.02535.x